CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Current assets:
Cash and cash equivalents	$ 654,587	$ 648,719
Marketable securities	241,055	251,761
Accounts receivable - trade, net	1,088,207	739,379
Accounts Receivable from Sanofi	199,117	111,510
Accounts receivable from Bayer HealthCare	151,991	125,483
Inventories	190,668	128,861
Deferred tax assets	60,521	46,179
Prepaid expenses and other current assets	89,494	79,046
Total current assets	2,675,640	2,130,938
Marketable securities	681,326	460,154
Property, plant, and equipment, at cost, net of accumulated depreciation and amortization	1,475,123	974,309
Deferred tax assets	346,243	269,237
Other assets	4,583	3,034
Total assets	5,182,915	3,837,672
Current liabilities:
Accounts payable and accrued expenses	577,428	483,489
Deferred revenue from Sanofi, current portion	100,908	15,927
Deferred revenue - other, current portion	54,148	58,098
Other Liabilities, Current	2,506	97,146
Total current liabilities	734,990	654,660
Deferred revenue from Sanofi	599,339	62,819
Deferred Revenue - other	78,942	72,430
Facility lease obligations	364,144	310,938
Convertible senior notes	30,723	146,773
Other long-term liabilities	77,910	39,801
Total liabilities	1,886,048	1,287,421
Stockholders' equity:
Preferred Stock	0	0
Additional paid-in capital	2,880,109	2,450,782
Retained earnings	697,706	216,644
Accumulated other comprehensive income	7,721	52,251
Treasury stock	(288,777)	(169,530)
Total stockholders' equity	3,296,867	2,550,251
Total liabilities and stockholders' equity	5,182,915	3,837,672
Class A Stock
Stockholders' equity:
Common stock	2	2
Common Stock
Stockholders' equity:
Common stock	$ 106	$ 102